Ardelyx, Inc. (FRA:41X)

Germany · Delayed Price · Currency is EUR

4.959

-0.139 (-2.73%)

Last updated: Dec 1, 2025, 8:19 AM CET

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2011 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2011 - 2019
Biopharmaceutical Products	333.62M	Log In	Log In	Log In	Log In	Upgrade
Biopharmaceutical Products Growth	168.06%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2011 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2011 - 2019
United States	319.20M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	283.30%	Log In	Log In	Log In	Log In	Upgrade
Asia Pacific	14.34M	Log In	Log In	Log In	Log In	Upgrade
Asia Pacific Growth	-65.12%	Log In	Log In	Log In	Log In	Upgrade
North America	78.00K	Log In	Log In	Log In	Log In	Upgrade
North America Growth	32.20%	Log In	Log In	Log In	Log In	Upgrade